Stockreport

Results from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months [Yahoo! Finance]

Kiromic BioPharma, Inc.  (KRBP) 
PDF HOUSTON, February 14, 2024 BUSINESS WIRE Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") announces continued encouraging clinical findings from the m [Read more]